#

Dr. Hussein Bagha Speaks on CardioRenalMetabolic Disease at Sanofi KRA-FORCAR Forum in Mombasa

#Admin 20th May 2024

Dr. Hussein Bagha recently had the pleasure of speaking at the Sanofi KRA-FORCAR forum, where he focused on the prevention, evaluation, and treatment of chronic kidney disease (CKD) within the context of CardioRenalMetabolic Disease. The hybrid meeting attracted over 700 participants from across Africa, underscoring the widespread interest and urgent need to address this critical health issue.

In his presentation, Dr. Bagha highlighted the significant burden of CKD in Africa, emphasizing the need for proactive measures to prevent the development of CKD and to slow its progression in patients already affected. He discussed the interconnected nature of cardiovascular, renal, and metabolic diseases, and how integrated approaches are essential for effective management and improved patient outcomes.

Dr. Bagha's talk covered various strategies for preventing CKD, including early screening, lifestyle modifications, and the use of medications that protect both renal and cardiovascular health. He also explored the importance of timely and accurate evaluation of CKD to tailor appropriate treatment plans and to monitor disease progression effectively.

The forum provided a valuable platform for healthcare professionals from across the continent to exchange knowledge and best practices. Dr. Bagha's insights and expertise contributed significantly to the dialogue, offering practical solutions and encouraging collaborative efforts to tackle the growing challenge of CKD in Africa.

Reflecting on the event, Dr. Bagha expressed his appreciation for the opportunity to engage with a diverse group of healthcare professionals dedicated to improving the management of CardioRenalMetabolic Disease. He reiterated the importance of continued education, research, and community involvement in addressing the high prevalence of CKD and enhancing patient care.

Dr. Bagha's participation in the Sanofi KRA-FORCAR forum highlights his ongoing commitment to advancing the understanding and treatment of complex chronic conditions, ultimately aiming to reduce the burden of CKD and improve health outcomes across Africa.